{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:46:51Z","timestamp":1761486411815,"version":"3.37.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.gastrohep.2024.502216","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T19:29:33Z","timestamp":1717788573000},"page":"502216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preguntas comunes y respuestas razonadas sobre el s\u00edndrome del sobrecrecimiento bacteriano intestinal (SIBO)"],"prefix":"10.1016","volume":"48","author":[{"given":"Javier","family":"Alcedo Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferm\u00edn","family":"Estremera-Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julyssa","family":"Cobi\u00e1n Malaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Santos Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Gerardo","family":"Alcal\u00e1-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Naves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Barba Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Barber Caselles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Serrano-Falc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Accarino Garaventa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Alonso-Cotoner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Serra Pueyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2024.502216_bib0485","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2019.07.006","article-title":"The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions","volume":"9","author":"Kastl","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0490","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MOG.0000000000000971","article-title":"Small intestinal bacterial overgrowth: current update","volume":"39","author":"Zafar","year":"2023","journal-title":"Curr Opin Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0495","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gut.2005.075127","article-title":"Use and abuse of hydrogen breath tests","volume":"55","author":"Simr\u00e9n","year":"2006","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0500","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ajg.2017.46","article-title":"Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus","volume":"112","author":"Rezaie","year":"2017","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0505","doi-asserted-by":"crossref","first-page":"e0234906","DOI":"10.1371\/journal.pone.0234906","article-title":"The duodenal microbiome is altered in small intestinal bacterial overgrowth","volume":"15","author":"Leite","year":"2020","journal-title":"PLoS One."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0510","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gtc.2016.09.008","article-title":"Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders","volume":"46","author":"Ghoshal","year":"2017","journal-title":"Gastroenterol Clin North Am."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0515","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2020.06.090","article-title":"AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review","volume":"159","author":"Quigley","year":"2020","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0520","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12664-022-01292-x","article-title":"Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association","volume":"41","author":"Ghoshal","year":"2022","journal-title":"Indian J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0525","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/s41467-019-09964-7","article-title":"Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders","volume":"10","author":"Saffouri","year":"2019","journal-title":"Nat Commun."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0530","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s43440-023-00489-x","article-title":"Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics","volume":"75","author":"Kiecka","year":"2023","journal-title":"Pharmacol Rep."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0535","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ueg2.12133","volume":"10","author":"Hammer","year":"2022","journal-title":"United European Gastroenterol J."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0540","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/flgastro-2022-102163","article-title":"Aetiology, diagnosis and management of small intestinal bacterial overgrowth","volume":"14","author":"Ahmed","year":"2022","journal-title":"Frontline Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0545","doi-asserted-by":"crossref","first-page":"e00078","DOI":"10.14309\/ctg.0000000000000078","article-title":"Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management","volume":"10","author":"Rao","year":"2019","journal-title":"Clin Transl Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0550","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00535-018-1476-9","article-title":"Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis","volume":"53","author":"Chen","year":"2018","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0555","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10620-019-05889-9","article-title":"Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance","volume":"65","author":"Amieva-Balmori","year":"2020","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0560","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1007\/s10620-023-07999-x","article-title":"Clinical Presentation of Small Intestinal Bacterial Overgrowth from Aerodigestive Tract Bacteria Versus Colonic-Type Bacteria: A Comparison Study","volume":"68","author":"Siddique","year":"2023","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0565","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.cgh.2021.09.035","article-title":"Distinctive Clinical Correlates of Small Intestinal Bacterial Overgrowth with Methanogens","volume":"20","author":"Madigan","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0570","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cgh.2023.06.001","article-title":"Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing","volume":"22","author":"Leite","year":"2024","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"Pt 2","key":"10.1016\/j.gastrohep.2024.502216_bib0575","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1099\/jmm.0.022848-0","article-title":"Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome","volume":"60","author":"Kerckhoffs","year":"2011","journal-title":"J Med Microbiol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0580","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s10620-015-3607-y","article-title":"Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis","volume":"60","author":"Shukla","year":"2015","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0585","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1007\/s00253-021-11264-4","article-title":"Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients","volume":"105","author":"Sciavilla","year":"2021","journal-title":"Appl Microbiol Biotechnol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0590","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/gutjnl-2012-303013","article-title":"Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet","volume":"63","author":"Manichanh","year":"2014","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0595","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0600","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00535-017-1371-9","article-title":"Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth","volume":"53","author":"Su","year":"2018","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0605","doi-asserted-by":"crossref","first-page":"190","DOI":"10.14309\/ajg.0000000000000504","article-title":"Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies","volume":"115","author":"Shah","year":"2020","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0610","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10620-021-06857-y","article-title":"Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes","volume":"67","author":"Weitsman","year":"2022","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0615","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.gastro.2023.04.039","article-title":"AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review","volume":"165","author":"Moshiree","year":"2023","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0620","doi-asserted-by":"crossref","first-page":"e00073","DOI":"10.14309\/ctg.0000000000000073","article-title":"Characterization of Proximal Small Intestinal Microbiota in Patients With Suspected Small Intestinal Bacterial Overgrowth: A Cross-Sectional Study","volume":"10","author":"Shin","year":"2019","journal-title":"Clin Transl Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0625","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fcimb.2020.00151","article-title":"Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices","volume":"10","author":"Tang","year":"2020","journal-title":"Front Cell Infect Microbiol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0630","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5056\/jnm19113","article-title":"Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis","volume":"26","author":"Losurdo","year":"2020","journal-title":"J Neurogastroenterol Motil."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0635","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/gut.2009.205476","article-title":"Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS","volume":"60","author":"Yu","year":"2011","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0640","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2015.07.032","article-title":"Scintigraphy Demonstrates High Rate of False-positive Results From Glucose Breath Tests for Small Bowel Bacterial Overgrowth","volume":"14","author":"Lin","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0645","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10620-020-06623-6","article-title":"Small Intestinal Bacterial Overgrowth Syndrome: A Guide for the Appropriate Use of Breath Testing","volume":"66","author":"Massey","year":"2021","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0650","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10620-020-06776-4","article-title":"Every Breath Test You Take: Practical Advice on Breath Testing Used to Detect Small Intestinal Bacterial Overgrowth","volume":"66","author":"Camilleri","year":"2021","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0655","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.14309\/ajg.0000000000001997","article-title":"Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes","volume":"117","author":"Villanueva-Millan","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0660","doi-asserted-by":"crossref","first-page":"470","DOI":"10.14309\/ajg.0000000000001607","article-title":"A Single Fasting Exhaled Methane Level Correlates With Fecal Methanogen Load, Clinical Symptoms and Accurately Detects Intestinal Methanogen Overgrowth","volume":"117","author":"Takakura","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0665","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1348-0421.2004.tb03544.x","article-title":"Microbiota composition of the intestinal mucosa: association with fecal microbiota?","volume":"48","author":"Ouwehand","year":"2004","journal-title":"Microbiol Immunol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0670","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/apt.13399","article-title":"The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects","volume":"42","author":"Rangel","year":"2015","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0675","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1007\/s10620-022-07588-4","article-title":"Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome","volume":"67","author":"Hou","year":"2022","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0680","doi-asserted-by":"crossref","first-page":"1148097","DOI":"10.3389\/fmicb.2023.1148097","article-title":"Comparison of gut microbiome composition in colonic biopsies, endoscopically-collected and at-home-collected stool samples","volume":"14","author":"Nowicki","year":"2023","journal-title":"Front Microbiol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0685","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3748\/wjg.15.2887","article-title":"Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients","volume":"15","author":"Kerckhoffs","year":"2009","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0690","doi-asserted-by":"crossref","first-page":"1242242","DOI":"10.3389\/fimmu.2023.1242242","article-title":"Diversity of the microbiota communities found in the various regions of the intestinal tract in healthy individuals and inflammatory bowel diseases","volume":"14","author":"Lawal","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0695","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3390\/microorganisms11071822","article-title":"Volatile Organic Compound Assessment as a Screening Tool for Early Detection of Gastrointestinal Diseases","volume":"11","author":"Dalis","year":"2023","journal-title":"Microorganisms."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0700","doi-asserted-by":"crossref","first-page":"830356","DOI":"10.3389\/fnins.2022.830356","article-title":"Current and Future Approaches for Diagnosing Small Intestinal Dysbiosis in Patients With Symptoms of Functional Dyspepsia","volume":"16","author":"Shah","year":"2022","journal-title":"Front Neurosci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0705","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.14309\/ajg.0000000000000444","article-title":"Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea","volume":"114","author":"Rezaie","year":"2019","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0710","first-page":"412","article-title":"Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study","volume":"98","author":"Pimentel","year":"2003","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0715","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2020.02.018","article-title":"Predicting Response to Rifaximin in Irritable Bowel Syndrome with Diarrhea: Is the Answer Blowing in the Wind?","volume":"158","author":"Black","year":"2020","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0720","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s10620-018-5344-5","article-title":"Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome","volume":"64","author":"Tuteja","year":"2019","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0725","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s10620-015-3872-9","article-title":"Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome","volume":"61","author":"Kasir","year":"2016","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0730","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3346\/jkms.2015.30.6.757","article-title":"Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects","volume":"30","author":"Bae","year":"2015","journal-title":"J Korean Med Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0735","doi-asserted-by":"crossref","first-page":"971582","DOI":"10.1155\/2015\/971582","article-title":"Duodenal Aspirates for Small Intestine Bacterial Overgrowth: Yield, PPIs, and Outcomes after Treatment at a Tertiary Academic Medical Center","volume":"2015","author":"Franco","year":"2015","journal-title":"Gastroenterol Res Pract."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0740","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/jgh.13015","article-title":"Poor predictive value of breath hydrogen response for probiotic effects in IBS","volume":"30","author":"Yao","year":"2015","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0745","doi-asserted-by":"crossref","first-page":"e0214273","DOI":"10.1371\/journal.pone.0214273","article-title":"Fasting breath H2 and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome","volume":"14","author":"Le Nev\u00e9","year":"2019","journal-title":"PLoS One."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0750","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/B:DDAS.0000011605.43979.e1","article-title":"A 14-day elemental diet is highly effective in normalizing the lactulose breath test","volume":"49","author":"Pimentel","year":"2004","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0755","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jgh3.12899","article-title":"Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome (IBS): Correlating H2\u00a0or CH4\u00a0production with severity of IBS","volume":"7","author":"Onana Ndong","year":"2023","journal-title":"JGH Open."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0760","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cgh.2015.09.039","article-title":"Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome","volume":"14","author":"Le Nev\u00e9","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0765","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.3390\/nu14163382","article-title":"Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review","volume":"14","author":"Wielgosz-Grochowska","year":"2022","journal-title":"Nutrients."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0770","doi-asserted-by":"crossref","first-page":"102284","DOI":"10.1016\/j.coph.2022.102284","article-title":"Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome","volume":"66","author":"Algera","year":"2022","journal-title":"Curr Opin Pharmacol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0775","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/ajcn\/nqac176","article-title":"Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis","volume":"116","author":"So","year":"2022","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0780","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1136\/gutjnl-2021-325177","article-title":"Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet","volume":"71","author":"Vervier","year":"2022","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0785","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/apt.12479","article-title":"Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth","volume":"38","author":"Shah","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0790","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5056\/jnm22187","article-title":"Symptomatic Response to Antibiotics in Patients With Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-analysis","volume":"30","author":"Takakura","year":"2024","journal-title":"J Neurogastroenterol Motil."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0795","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: Rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0800","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/17474124.2021.2005579","article-title":"Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis","volume":"15","author":"Wang","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0805","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2036.2005.02562.x","article-title":"Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis","volume":"22","author":"Sajjad","year":"2005","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0810","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1572-0241.2001.03636.x","article-title":"Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function","volume":"96","author":"Madrid","year":"2001","journal-title":"Am J Gastroenterol."},{"issue":"11\u201312","key":"10.1016\/j.gastrohep.2024.502216_bib0815","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1046\/j.1365-2036.2003.01800.x","article-title":"Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease","volume":"18","author":"Castiglione","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0820","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0016-5085(99)70336-7","article-title":"Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial","volume":"117","author":"Attar","year":"1999","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0825","first-page":"111","article-title":"Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole","volume":"13","author":"Lauritano","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0830","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ueg2.12116","article-title":"The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth","volume":"9","author":"Richard","year":"2021","journal-title":"United European Gastroenterol J."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0835","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5056\/jnm22168","article-title":"Small Intestinal Bacterial Overgrowth Complicating Gastrointestinal Manifestations of Systemic Sclerosis: A Systematic Review and Meta-analysis","volume":"29","author":"Shah","year":"2023","journal-title":"J Neurogastroenterol Motil."},{"issue":"6 Suppl 86","key":"10.1016\/j.gastrohep.2024.502216_bib0840","first-page":"S-82","article-title":"Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms","volume":"32","author":"Tauber","year":"2014","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0965","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41575-022-00673-z","article-title":"Methanogenic archaea in the human gastrointestinal tract","volume":"19","author":"Hoegenauer","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0970","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1469-0691.2012.03913.x","article-title":"Susceptibility of archaea to antimicrobial agents: applications to clinical microbiology","volume":"18","author":"Khelaifia","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0975","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s10620-011-1590-5","article-title":"Methane on breath testing is associated with constipation: a systematic review and meta-analysis","volume":"56","author":"Kunkel","year":"2011","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0980","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s10620-014-3157-8","article-title":"Antibiotic treatment of constipation-predominant irritable bowel syndrome","volume":"59","author":"Pimentel","year":"2014","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0985","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MCG.0b013e3181c64c90","article-title":"A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test","volume":"44","author":"Low","year":"2010","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0870","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1572-0241.2008.02030.x","article-title":"Small intestinal bacterial overgrowth recurrence after antibiotic therapy","volume":"103","author":"Lauritano","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0875","doi-asserted-by":"crossref","first-page":"e0003923","DOI":"10.1128\/cmr.00039-23","article-title":"The potential for development of clinically relevant microbial resistance to rifaximin-\u221d: a narrative review","volume":"36","author":"DuPont","year":"2023","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0880","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000443361","article-title":"The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin","volume":"34","author":"Ponziani","year":"2016","journal-title":"Dig Dis."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0885","doi-asserted-by":"crossref","first-page":"e0121521","DOI":"10.1128\/mSystems.01215-21","article-title":"Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation","volume":"6","author":"Phan","year":"2021","journal-title":"mSystems."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0890","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/ph16071041","article-title":"Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats","volume":"16","author":"Aslan","year":"2023","journal-title":"Pharmaceuticals (Basel)."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0895","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/apt.14539","article-title":"European Society for Primary Care Gastroenterology. Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus","volume":"47","author":"Hungin","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0900","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s12602-018-9401-3","article-title":"Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth","volume":"11","author":"Leventogiannis","year":"2019","journal-title":"Probiotics Antimicrob Proteins."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0905","doi-asserted-by":"crossref","first-page":"4181748","DOI":"10.1155\/2020\/4181748","article-title":"Effect of Combined Live Probiotics Alleviating the Gastrointestinal Symptoms of Functional Bowel Disorders","volume":"2020","author":"Shi","year":"2020","journal-title":"Gastroenterol Res Pract."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0910","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1159\/000528954","article-title":"Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study","volume":"41","author":"Bustos Fern\u00e1ndez","year":"2023","journal-title":"Dig Dis."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0915","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence","volume":"51","author":"Zhong","year":"2017","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0920","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11695-020-04900-x","article-title":"Effects of Probiotics Supplementation on Gastrointestinal Symptoms and SIBO after Roux-en-Y Gastric Bypass: a Prospective, Randomized, Double-Blind, Placebo-Controlled Trial","volume":"31","author":"Wagner","year":"2021","journal-title":"Obes Surg."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0925","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/MEG.0000000000000214","article-title":"Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease","volume":"26","author":"Kwak","year":"2014","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0930","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3390\/jcm13030919","article-title":"Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study","volume":"13","author":"Efremova","year":"2024","journal-title":"J Clin Med."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0935","doi-asserted-by":"crossref","first-page":"983027","DOI":"10.3389\/fcimb.2022.983027","article-title":"Efficacy evaluation of probiotics combined with prebiotics in patients with clinical hypothyroidism complicated with small intestinal bacterial overgrowth during the second trimester of pregnancy","volume":"12","author":"Hao","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0940","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s10620-019-05830-0","article-title":"Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis","volume":"65","author":"Garc\u00eda-Collinot","year":"2020","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0945","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10620-018-4945-3","article-title":"Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth","volume":"63","author":"Kumar","year":"2018","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0950","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41424-018-0030-7","article-title":"Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis","volume":"9","author":"Rao","year":"2018","journal-title":"Clin Transl Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0955","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.curtheres.2015.04.002","article-title":"Effects of Daikenchuto on Abdominal Bloating Accompanied by Chronic Constipation: A Prospective, Single-Center Randomized Open Trial","volume":"77","author":"Yuki","year":"2015","journal-title":"Curr Ther Res Clin Exp."},{"key":"10.1016\/j.gastrohep.2024.502216_bib0960","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7453\/gahmj.2014.019","article-title":"Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth","volume":"3","author":"Chedid","year":"2014","journal-title":"Glob Adv Health Med."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570524001985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570524001985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T09:38:46Z","timestamp":1738748326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570524001985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0210570524001985"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2024.502216","relation":{},"ISSN":["0210-5705"],"issn-type":[{"type":"print","value":"0210-5705"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preguntas comunes y respuestas razonadas sobre el s\u00edndrome del sobrecrecimiento bacteriano intestinal (SIBO)","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2024.502216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"502216"}}